A high throughput assay for identification of hepatitis C virus NS3 serine protease inhibitors.

被引：0
|
作者：
Zemel, R
Berdichevsky, Y
Bachmatove, L
Kunin, M
Golan-Goldhirsh, A
Tur-Kaspa, R
Benhar, I
机构：
[1] Tel Aviv Univ, Felsenstein Med Res Ctr, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Petah Tiqwa, Israel
[3] Ben Gurion Univ Negev, Beer Sheva, Israel
[4] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1003
引用
收藏
页码：423A / 423A
页数：1
相关论文
共 50 条
  • [31] Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease
    Kirschberg, Thorsten A.
    Squires, Neil H.
    Yang, Huiling
    Corsa, Amoreena C.
    Tian, Yang
    Tirunagari, Neeraj
    Sheng, X. Christopher
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 969 - 972
  • [32] Molecular docking of peptide inhibitors to the hepatitis C virus NS3 protease
    Shenderovich, M
    Wang, J
    Fisher, C
    Ramnarayan, K
    Abagyan, R
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 472 - 473
  • [33] High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors
    Lee, JC
    Yu, MC
    Lien, TW
    Chang, CF
    Hsu, JTA
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2005, 3 (04) : 385 - 392
  • [34] AN IN-VITRO ASSAY FOR HEPATITIS-C VIRUS NS3 SERINE PROTEINASE
    BOUFFARD, P
    BARTENSCHLAGER, R
    AHLBORNLAAKE, L
    MOUS, J
    ROBERTS, N
    JACOBSEN, H
    VIROLOGY, 1995, 209 (01) : 52 - 59
  • [35] Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors
    Raboisson, Pierre
    Lin, Tse-I
    de Kock, Herman
    Vendeville, Sandrine
    de Vreken, Wim Van
    McGowan, David
    Tahri, Abdellah
    Hu, Lili
    Lenz, Oliver
    Delouvroy, Frederic
    Surleraux, Dominique
    Wigerinck, Piet
    Nilsson, Magnus
    Rosenquist, Asa
    Samuelsson, Bertil
    Simmen, Kenneth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) : 5095 - 5100
  • [36] An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA
    Pause, A
    Kukolj, G
    Bailey, M
    Brault, M
    Dô, F
    Halmos, T
    Lagacé, L
    Maurice, R
    Marquis, M
    McKercher, G
    Pellerin, C
    Pilote, L
    Thibeault, D
    Lamarre, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) : 20374 - 20380
  • [37] Cell transformation induced by hepatitis C virus nonstructural NS3 serine protease.
    Gerecht, S
    Zemel, R
    Bachmatove, L
    Grief, H
    Tur-Kaspa, R
    HEPATOLOGY, 1999, 30 (04) : 356A - 356A
  • [38] NS3 IS A SERINE-PROTEASE REQUIRED FOR PROCESSING OF HEPATITIS-C VIRUS POLYPROTEIN
    TOMEI, L
    FAILLA, C
    SANTOLINI, E
    DEFRANCESCO, R
    LAMONICA, N
    JOURNAL OF VIROLOGY, 1993, 67 (07) : 4017 - 4026
  • [39] Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection
    Mederacke, Ingmar
    Wedemeyer, Heiner
    Manns, Michael P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (02) : 181 - 189
  • [40] Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors
    Sheng, X. Christopher
    Pyun, Hyung-Jung
    Chaudhary, Kleem
    Wang, Jianying
    Doerffler, Edward
    Fleury, Melissa
    McMurtrie, Darren
    Chen, Xiaowu
    Delaney, William E.
    Kim, Choung U.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3453 - 3457
12345